Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Immune Deficiency”

124 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 124 results

Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Early research (Phase 1)Study completedNCT01638650
What this trial is testing

Ritonavir-Boosted Invirase (Saquinavir) in Treatment-Naïve HIV-1 Infected Patients

Who this might be right for
HIV Infections
Hoffmann-La Roche 23
Not applicableStudy completedNCT00886990
What this trial is testing

Efficacy and Safety of Single Versus Double Ritonavir-boosted Protease Inhibitor (PI)-Based Antiretroviral Therapy (ART) Regimens

Who this might be right for
HIV InfectionHIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 240
Post-approval studies (Phase 4)UnknownNCT03017872
What this trial is testing

Dolutegravir and Darunavir Evaluation in Adults Failing Therapy

Who this might be right for
HIV Infections
Kirby Institute 831
Not applicableStudy completedNCT02303093
What this trial is testing

Non-Interventional Study on the Tolerability and Efficacy of IVIG

Who this might be right for
Primary and Secondary Immunodeficiency and Other Conditions Requiring Regular Administration of Octagam 5% or 10% IVIG
Octapharma 344
Large-scale testing (Phase 3)Study completedNCT00038519
What this trial is testing

Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor

Who this might be right for
HIV Infections
Abbott 16
Not applicableNot Yet RecruitingNCT07689812
What this trial is testing

Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Carcinoma)+12 more
Natera, Inc. 920
Not applicableStudy completedNCT00884793
What this trial is testing

Pilot Study on the Effect of Adding Raltegravir +/- a Second Drug on HIV Levels in the Gut

Who this might be right for
HIV Infections
University of California, San Francisco 8
Not applicableStudy completedNCT04172467
What this trial is testing

Quality Assurance of Secondary Immunodeficiencies (SID) in CLL/MM Patients

Who this might be right for
Secondary Immunodeficiencies (SID)
AIO-Studien-gGmbH 1,086
Not applicableStudy completedNCT04036097
What this trial is testing

Prospective Stratification of Infectious Risks in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University Hospital, Basel, Switzerland 298
Not applicableUnknownNCT03705611
What this trial is testing

Secondary Distribution of HIV Self-tests Through Antenatal Care Clinic Attendees and Index Clients

Who this might be right for
HIV/AIDSHIV Infections
London School of Hygiene and Tropical Medicine 10,000
Not applicableStudy completedNCT00002263
What this trial is testing

A Pilot Study to Evaluate the Effects of Subcutaneously Administered Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Pediatric HIV-Infected Patients With Neutropenia Secondary to Azidothymidine

Who this might be right for
HIV InfectionsCytopenias
Sandoz
Not applicableNot Yet RecruitingNCT07189013
What this trial is testing

Assessing Patient Preference for Infusion Systems

Who this might be right for
Primary Immunodeficiencies (PID)Secondary Immunodeficiencies (SID)
KORU Medical Systems, Inc. 52
Not applicableStudy completedNCT00050089
What this trial is testing

CSP #512 - Options in Management With Anti-Retrovirals

Who this might be right for
AIDSHIV Infections
US Department of Veterans Affairs 368
Early research (Phase 1)Looking for participantsNCT06513819
What this trial is testing

HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 2 (2nd HARP Pilot Intervention)

Who this might be right for
HivAlcohol DrinkingFall+1 more
Yale University 100
Large-scale testing (Phase 3)Looking for participantsNCT07648264
What this trial is testing

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

Who this might be right for
Secondary Immune Deficiency
CSL Behring 63
Testing effectiveness (Phase 2)Study completedNCT03304093
What this trial is testing

Immunotherapy by Nivolumab for HIV+ Patients

Who this might be right for
Non Small Cell Lung Cancer MetastaticNon Small Cell Lung Cancer Stage IIIBHIV/AIDS
Intergroupe Francophone de Cancerologie Thoracique 30
Testing effectiveness (Phase 2)Study completedNCT01368107
What this trial is testing

Study Evaluating Impact of IL-7 on CD4 Lymphopenia, Risks of Severe Haematological Toxicity and Tumor Progression in Metastatic Breast Cancer Patients

Who this might be right for
Metastatic Breast Cancer
Centre Leon Berard 24
Not applicableStudy completedNCT03054181
What this trial is testing

Facilitated Immunoglobulin Administration Registry and Outcomes Study (FIGARO)

Who this might be right for
Primary ImmunodeficiencySecondary Immune Deficiency
GWT-TUD GmbH 156
Large-scale testing (Phase 3)Looking for participantsNCT06980480
What this trial is testing

Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma

Who this might be right for
Multiple MyelomaSecondary Immunodeficiency
Takeda 183
Next Page